from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3131/-

LFCtreatmentdescriptionclass of inhibitor

0.622

Amikacinug/mL Amikacintranslation

0.917

Cap5-10ug/mL Capreomycintranslation

0.541

Rox10-50 ug/mL Roxithromycintranslation

0.368

SM2-5 ug/mL Streptomycintranslation

-1.863

Tet5-10 ug/mL Tetracyclinetranslation

0.516

Rif0.2-5ug/mL Rifampicintranscription

-0.661

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.672

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.614

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.900

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.171

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.029

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.382

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.518

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.634

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.205

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.286

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.548

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.352

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.798

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.367

KCN5-20 ug/mL Potassium cyaniderespiration

0.417

NaN30.2-2 mM Sodium aziderespiration

-0.354

Nigericin50 uM Nigericinrespiration

-0.052

TRC10-150 ug/mL Triclosanrespiration

-0.514

TRZ10-25 ug/mL Thioridazinerespiration

-0.561

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.069

menadione6-10 ug/mL Menadionerespiration

-0.537

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.078

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.157

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.349

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.411

NRP_1Non-replicating persistence stage 1dosRassociated

0.512

Amp0.2mg/mL AmpicillincellWall

-0.128

Cephalexin20-100 ug/mL CephalexincellWall

0.349

Cerulenin0.32-5 ug/mL CerulenincellWall

0.343

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.093

EMB10-20 ug/mL EthambutolcellWall

0.164

Eta12-40 ug/mL EthionamidecellWall

0.294

INH0.2-0.4 ug/mL IsoniazidcellWall

0.182

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.286

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.627

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.029

BZA0.12 mg/mL BenzamidearomaticAmides

-0.471

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.630

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.333

H2O24 mM hydrogen peroxideDNAdamaging

0.650

Levo10 ug/mL LevofloxacinDNAdamaging

-0.219

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.561

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.449

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.205

UVUV-irradiationDNAdamaging

-0.363

ARP41-4 ug/mL Antitubercular compound ARP4?

0.378

Antimycin12.5-50 ug/mL Antimycin A?

-0.392

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.251

PA_110-50 ug/mL Antitubercular compound PA-1?

0.267

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.144

PA8240.2-2 ug/mL PA-824?

2.444

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.135

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.168

Verapamil50 uM Verapamil?

-0.081

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.876

methoxatin10-20 ug/mL Methoxatin?